Back to search results

Home Care After Stem Cell Transplant Study

This study is looking at how home care after an autologous hematopoietic stem cell transplant (a procedure where you receive your own stem cells) affects the well-being of caregivers. Researchers want to see if caregivers experience less strain when patients receive care at home compared to standard hospital care. You might be able to join if you are between 18 and 80 years old, scheduled for this type of transplant for cancer or another illness, can read and write English, and live within a 90-minute drive of Duke in a home suitable for medical care. The study will measure caregiver well-being using a tool called the Caregiver Strain Index after 14 days. The current enrollment status is unclear.

Study design
This is an interventional study planning to enroll 150 participants. It compares home care to standard care after a stem cell transplant.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Caregiver well-being will be measured at 14 days after the transplant.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03667599

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Recruiting
NAAges 18–80InterventionalSupportive care
Duke University
~150 participants
Updated 2025-03-17 on ClinicalTrials.gov
What's tested:home care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Quality of Life in Caregivers (Caregiver Strain Index)
Measured over 14 days

Conditions

Well-being of Caregivers (Caregiver Strain Index)

Explore related trials

Hematopoietic Cell Transplantation

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Anthony Sung, MD · PRINCIPAL_INVESTIGATOR · Duke Health
  • Nelson Chao, MD · PRINCIPAL_INVESTIGATOR · Duke Health

Who to contact

Andrea Pires, MS
[email protected]
919-613-1546
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
Age 18-80 years
Karnofsky Performance Scale KPS\> 80
Able to read/write English
A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
Identified by patient as their primary caregiver
Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
Age 18-80 years

Exclusion

Lack of a caregiver
Pregnant women
Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota

What this trial measures

  • Quality of Life in Caregivers (Caregiver Strain Index)14 days

    To compare the quality of life (Caregiver Strain Index) in caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.